New York State Common Retirement Fund Glycomimetics Inc Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$1.8 - $2.39 $576 - $764	-320 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$2.16 - $3.18 $61,732 - $90,884	-28,580 Reduced 98.89%	320 $1,000
Q2 2019 Aug 09, 2019	SELL	$10.6 - $13.12 $89,040 - $110,208	-8,400 Reduced 22.52%	28,900 $344,000
Q2 2018 Aug 10, 2018	BUY	$14.63 - $19.19 $545,699 - $715,787	37,300 New	37,300 $602,000

25.6M

1.94M

153K

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $8.91M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.